A Conceptual Model for Pharmaceutical Pricing

Chandan Dutta

Abstract


The reasearch work is an attempt to suggest a model for the pricing of generic drugs.

Full Text:

PDF

References


Carly Z (July 2008), Branded Pharmaceutical Companies Can Expect to See Sales Drops of up to 70 Percent after Patent Expiration from Generic Competition. Advertising Industry Newswire

How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry. Congressional Budget Office, Washington, DC, July 1998

Debra B. Feinberg (2007), Pharmacy Law. Published by McGraw-Hill Professional

The Pharmaceutical Market. Report by German Association of Research-Based Pharmaceutical Companies (vfa), 2009

The History and Analysis of the Pharmaceutical Industry. Case Study by Verbigena

The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses. Business Insights, July 2008

Jacob Goldstein (October 2008), Pfizer Goes Generic. Wall Street Journal

Danzon, Epstein, and Nicholson (May 2004), Mergers and Acquisitions in the Pharmaceutical and Biotech Industries. Wharton School

Pfizer's acquisition of Wyeth brings scale but will fail to deliver sustainable sales growth. Datamonitor staff writer, January 2009

Loden, D John,Liebman, Milton (March 2000), High compression marketing superchanges drug revenues. Medical Marketing and Media

Shopper's Guide to Prescription Drugs - Number 2: Generic Drugs. Consumer Report, Best Buy Drugs, 2006

Steven Seget (Feb 2003), Pharmaceutical Pricing Strategies: Optimizing returns throughout R&D and marketing. Business Insights

Reiffen and Ward, February 2002, Generic Drug Industry Dynamics.

Robert I. Chien (1979), Issues in Pharmaceutical Economics. Lexington Books

Price Trends for Frequently Used Brand and Generic Drugs from 2000 through 2004. United States Government Accountability Office, Washington DC, August 2005

Generics Threats and Opportunities: Mounting an Effective Defense Strategy. Publisher - Eularis, June 2008

Patent litigation the most commonly used generic defense strategy among pharmaceutical companies. Medical Patent News, November 2004

Generics Defense Strategies: Effective Brand Protection through Patent, Formulation, OTC and DTC Strategies. Business Insights, Jan 2005

Rupali Mukherjee, Pharma M&A Wave Set to Reach India. Times of India, March 2009


Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Chandan Dutta